| Digestive System Neoplasms |
| Not yet recruiting | 4 | 1500 | RoW | Vitamin D3 | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Carcinoma, Hepatocellular | 06/16 | 12/26 | | |
NCT02435953: TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma |
|
|
| Recruiting | 4 | 1 | RoW | TACE, RFA | Ming Zhao | Hepatocellular Carcinoma, Chemoembolization, Therapeutic, Ablation Techniques, RFA | 05/23 | | | |
| Not yet recruiting | 4 | 340 | RoW | laparoscopic surgery(LS), RFA | Sun Yat-sen University, Second Military Medical University | Hepatocellular Carcinoma | 12/26 | 12/26 | | |
PROCAPP, NCT01626781: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer |
|
|
| No Longer Available | 3 | | Europe | Mapisal, Urea hand-foot cream | AIO-Studien-gGmbH | the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine | | | | |
| Active, not recruiting | 3 | 788 | Europe | cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine | Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG | Gastric Cancer | 12/18 | 12/25 | | |
NCT02852915: Laparoscopic Surgery for T4 Tumor of the Colon Cancer |
|
|
| Not yet recruiting | 3 | 1960 | RoW | Laparoscopic surgery, Laparoscopic surgery for T4 colon cancers | LI XIN-XIANG | Colonic Neoplasms | 10/19 | 10/24 | | |
APREMEC, NCT02607072: Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial |
|
|
| Recruiting | 3 | 3000 | RoW | Acetylsalicylic acid (ASA)/aspirin 200 mg daily, Acetylsalicylic acid (ASA)/aspirin 100 mg daily, Placebo | The Fourth Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital | Colorectal Cancer | 10/20 | 10/22 | | |
NCT02461043: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 3 | 386 | RoW | paclitaxel; cisplatin, radiation | Chinese Academy of Medical Sciences | Esophageal Cancer | 12/20 | 12/23 | | |
NCT02635503: Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer |
|
|
| Recruiting | 3 | 366 | RoW | transrectal specimen extraction, NOSE, Conventional laparoscopic surgery, CLS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Colorectal Cancer | 12/20 | 12/25 | | |
ETAP, NCT02584985: Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal Cancer |
|
|
| Recruiting | 3 | 226 | Europe | ETAP, Standard Transabdominal Laparoscopic Proctectomy | Institut Paoli-Calmettes | Rectal Cancer | 01/21 | 01/24 | | |
APEC, NCT02965248: Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer ( Study) |
|
|
| Recruiting | 3 | 147 | RoW | Standard adjuvant systemic chemotherapy, adjuvant oxaliplatin, 5-FU, and leucovorin calcium (mFOLFOX6), adjuvant oxaliplatin and capecitabine (CapeOx), adjuvant 5-FU and leucovorin calcium (sLV5FU2), adjuvant capecitabine (Cape), Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed, Intraperitoneal raltitrexed 3 mg/m2, Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin, I.V. leucovorin calcium 20 mg/m2, I.V. 5-FU 400 mg/m2, Intraperitoneal oxaliplatin 130 mg/m2 | Fudan University | Locally Advanced Colorectal Cancer | 11/21 | 11/23 | | |
RESCUE-GC, NCT02867839: Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 564 | RoW | Oxaliplatin plus S-1, SOX, S-1 only, S-1 | Peking University Cancer Hospital & Institute | Gastric Cancer | 02/22 | 02/24 | | |
NCT02715492: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. |
|
|
| Not yet recruiting | 3 | 40 | RoW | LMWH, Enoxaparin, TACE | Sherief Abd-Elsalam | HCC | 12/22 | 12/22 | | |
OLCMECC, NCT02682589: Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer |
|
|
| Recruiting | 3 | 1080 | RoW | Open surgery, Laparoscopic surgery | The First Affiliated Hospital with Nanjing Medical University, West China Hospital, Changhai Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Fujian Medical University, First Affiliated Hospital of Chongqing Medical University | Colon Cancer | 04/23 | 04/23 | | |
PEPCORLI, NCT02912052: Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis |
|
|
| Not yet recruiting | 3 | 240 | RoW | Peri-operative chemotherapy, XELOX, postoperative chemotherapy | The First Affiliated Hospital with Nanjing Medical University | Colon Cancer | 10/23 | 10/23 | | |
SANO, NCT02705651: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment |
|
|
| Not yet recruiting | 3 | 180 | NA | Somatostatin-Analog | Medical University of Vienna | Pancreatic Neuroendocrine Tumors in MEN1 | 10/23 | 10/24 | | |
NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 620 | RoW | Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy | Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou | Gastric Cancer | 12/23 | 12/25 | | |
NCT02646137: Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma |
|
|
| Recruiting | 3 | 50 | RoW | Transarterial chemoembolization (TACE), Transarterial chemoembolization, Radiofrequency ablation combined with TACE, Microwave ablation combined with TACE | Sherief Abd-Elsalam, Tanta University | Liver Cancer | 12/23 | 12/23 | | |
| Not yet recruiting | 3 | 140 | Europe | Standard surgical treatment, Proactive management, Standard adjuvant systemic chemotherapy, adjuvant capecitabine and oxaliplatin (CAPOX), adjuvant 5-FU and oxaliplatin (FOLFOX) | University of Roma La Sapienza | Colon Cancer, Intraperitoneal Rectal Cancer | 09/24 | 09/25 | | |
| Active, not recruiting | 3 | 95000 | US, Europe, RoW | Colonoscopy | Oslo University Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Erasmus Medical Center, Landspitali University Hospital, Uppsala University Hospital, Karolinska Institutet, Memorial Sloan Kettering Cancer Center, Harvard School of Public Health (HSPH) | Colorectal Cancer | 06/26 | 07/36 | | |
| Not yet recruiting | 3 | 1800 | RoW | Aspirin, acetylsalicylic acid | Tel-Aviv Sourasky Medical Center, Rambam Health Care Campus, Rabin Medical Center, Soroka University Medical Center, Sheba Academic Medical Center Hospital | Lynch Syndrome I (Site-specific Colonic Cancer) | 09/27 | 09/27 | | |
| Recruiting | 2/3 | 584 | Europe | Carboplatin, Paclitaxel, Cisplatin, Capecitabine, Radiotherapy | Lisette Nixon, Cancer Research UK | Oesophageal Cancer | 04/21 | 04/23 | | |
PACHA-01, NCT02494973: Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases |
|
|
| Suspended | 2/3 | 104 | Europe | Oxaliplatin HAI, Oxaliplatin IV, mFOLFOX6, LV5FU2 | Gustave Roussy, Cancer Campus, Grand Paris, National Cancer Institute, France | Colorectal Cancer | 05/28 | 05/28 | | |
NCT01786850: Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer |
|
|
| Available | 2 | | Europe | Magnetic Resonance-guided High-intensity Focused Ultrasound (MRgFUS) | University of Roma La Sapienza | Pancreas, Cancer, Locally Advanced Pancreatic Cancer, Non-invasive Treatment | | | | |
NCT02231476: Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients |
|
|
| Recruiting | 2 | 60 | RoW | Zoledronic acid, Zolenic, Zometa | Severance Hospital | Bone Metastasis, Gastrointestinal Cancer | 01/16 | 01/16 | | |
SES-DTA, NCT02682485: Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing |
|
|
| Withdrawn | 2 | 200 | NA | Cipro, metronidazole, neomycin combo, Cipro/CiproXR/CiproIV; Flagyl/FlagylER/Metro; Neomycin, Serial Endoscopic Surveillance, SES, Saline, 0.9% saline solution | University of Chicago | Anastomotic Leak, Rectal Cancer | 03/17 | 03/17 | | |
NCT02942563: Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 100 | RoW | FOLFOXIRI, Irinotecan, Oxaliplatin, 5-FU, Capecitabine | RenJi Hospital | Rectal Cancer | 09/19 | 09/22 | | |
NCT02632864: Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial |
|
|
| Recruiting | 2 | 66 | RoW | Proton arm | Samsung Medical Center | Liver Neoplasm, Proton Therapy | 10/19 | 11/22 | | |
REALIZATION, NCT02404753: A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy |
|
|
| Active, not recruiting | 2 | 102 | RoW | Neoadjuvant Chemotherapy, NACT, Laparoscopic gastrectomy, LDG, Open gastrectomy, ODG, Adjuvant Chemotherapy, ACT | Peking University, Beijing Municipal Science & Technology Commission | Gastric Cancer | 11/20 | 11/22 | | |
NCT02510378: Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases |
|
|
| Recruiting | 2 | 47 | RoW | Short course radiotherapy | Chinese Academy of Medical Sciences | Stage IV Rectal Cancer, Liver Metastasis, Resectable | 12/20 | 12/22 | | |
NeoART-V, NCT03093129: Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer |
|
|
| Recruiting | 2 | 200 | RoW | artesunate, Arinate®, placebo | The 108 Military Central Hospital, Institute of Tropical Medicine, University of Tuebingen | Colorectal Cancer | 12/21 | 12/22 | | |
NCT00962520: Tarceva With Chemoradiation and Adjuvant Chemotherapy for Resectable Pancreatic Cancer |
|
|
| Active, not recruiting | 2 | 40 | US | Erlotinib, Tarceva, capecitabine, Xeloda, Radiation Therapy, gemcitabine, Gemzar, erlotinib | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Genentech, Inc. | Pancreatic Cancer | 04/22 | 04/23 | | |
|
|
OCCLURANDOM, NCT02230176: Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II |
|
|
| Recruiting | 2 | 80 | Europe | Sunitinib, 177Lu-DOTA0-Tyr3-Octreotate | Gustave Roussy, Cancer Campus, Grand Paris, National Cancer Institute, France, Advanced Accelerator Applications | Pancreatic Neuroendocrine Carcinoma | 10/23 | 10/23 | | |
| Recruiting | 2 | 100 | Europe | Bevacizumab plus alternating Xelox/Xeliri, Avastin, Xeloda, irinotecan, oxaliplatin | Pia Osterlund | Metastatic Colorectal Cancer | 12/25 | 12/25 | | |
NCT02485015: The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer |
|
|
| Active, not recruiting | 2 | 80 | RoW | Cytokine-Induced Killer Cells, CIK, Apatinib, YN968D1 | The First People's Hospital of Changzhou | Stomach Neoplasms | 06/30 | 06/33 | | |
NCT02490735: CIK in Treating Patients With Esophageal Cancer |
|
|
| Not yet recruiting | 2 | 2000 | RoW | Cytokine-induced Killer Cells, CIK | The First People's Hospital of Changzhou | Esophageal Squamous Cell Carcinoma | 08/40 | 08/42 | | |
NCT02487992: The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer |
|
|
| Active, not recruiting | 2 | 1200 | RoW | Cytokine-Induced Killer Cells | The First People's Hospital of Changzhou | Colorectal Neoplasms | 07/43 | 07/45 | | |
HyRec, NCT01716949: Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer |
|
|
| Recruiting | 1/2 | 59 | Europe | Radiotherapy, Hyperthermia, 5-Fluorouracil, all brands of 5-Fluorouracil are allowed, Capecitabine, all brands of Capecitabine are allowed, Oxaliplatin, all brands of oxaliplatin are allowed | University of Erlangen-Nürnberg Medical School | Rectal Cancer | 06/22 | 06/23 | | |
NCT02209441: Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer |
|
|
| Available | 1 | | RoW | Phase I Dose-finding Study of Sorafenib Study | Chinese Academy of Medical Sciences | Gastric Cancer. | | | | |
NCT03081377: Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in HCC |
|
|
| Recruiting | 1 | 15 | US | Galunisertib 150mg by mouth twice a day, (LY2157299), SBRT | University of Pennsylvania | Hepatocellular Carcinoma | 09/18 | 09/20 | | |
NCT02496273: Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer |
|
|
| Active, not recruiting | 1 | 60 | RoW | CTL, CEA Specific Cytotoxic T-Lymphocytes | The First People's Hospital of Changzhou | Gastric Cancer | 12/26 | 12/30 | | |
| Active, not recruiting | N/A | 650 | US | | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Barrett's Esophagus, Esophageal Neoplasm | | | | |
NCT01728051: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver |
|
|
| No Longer Available | N/A | | US | Melphalan, Percutaneous Hepatic Perfusion | Delcath Systems Inc. | Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma | | | | |
NCT02082691: Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma |
|
|
| No Longer Available | N/A | | US | G-202 | Devalingam Mahalingam, GenSpera, Inc. | Hepatocellular Carcinoma | | | | |
NCT00589030: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
|
|
| No Longer Available | N/A | | US | brachytherapy, yttrium Y 90 glass microspheres | City of Hope Medical Center | Liver Cancer | 09/14 | 09/14 | | |
NCT01646593: Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy |
|
|
| No Longer Available | N/A | | US | Regorafenib (BAY73-4506) | Bayer | Gastrointestinal Stromal Tumors | | | | |
NCT01613053: Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination |
|
|
| No Longer Available | N/A | | RoW | Glivec | Novartis Pharmaceuticals | Gastrointestinal Stromal Tumor | | | | |
| Active, not recruiting | N/A | 280 | Europe | Open liver resection, Open liver resection using standard technique:, Ligasure, CUSA, Thunderbeat, Autosonix, SonoSurg, Ultrasound, Laparoscopic liver resection, Laparoscopic liver resection using standardized technique:, Laparoscopic ultrasound | Oslo University Hospital, Helse Sor-Ost | Secondary Malignant Neoplasm of Liver, Colorectal Neoplasms | 04/16 | 12/25 | | |
NCT01689376: Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program) |
|
|
| No Longer Available | N/A | | RoW | Regorafenib (BAY73-4506) | Bayer | Gastrointestinal Stromal Tumors | | | | |
NCT02836977: Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection |
|
|
| Active, not recruiting | N/A | 400 | RoW | tegafur-uracil, UFUR | Kaohsiung Medical University Chung-Ho Memorial Hospital | Stage III Colon Cancer | 03/17 | 02/24 | | |
NCT02448056: MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma |
|
|
| Not yet recruiting | N/A | 150 | RoW | | National Taiwan University Hospital, Far Eastern Memorial Hospital | Carcinoma, Hepatocellular, Marker, Biological | 05/17 | 05/25 | | |
NCT00701168: Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer |
|
|
| No Longer Available | N/A | | US | yttrium Y 90 microspheres (Therasphere®) | Leo W. Jenkins Cancer Center | Carcinoma, Hepatocellular, Neoplasm Metastasis | | | | |
PURSE, NCT02564224: Study Comparing Pursestring Wound Closure vs Conventional Closure to Reverse Stoma of Colorectal Cancer Patients |
|
|
| No Longer Available | N/A | | RoW | Pursestring Wound Closure, Conventional Wound Closure, prolene | Zhejiang University | Colorectal Cancer, Stoma Closure Technic | | | | |
NCT02131441: Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection |
|
|
| Recruiting | N/A | 2 | RoW | laparoscopic hepatectomy, open liver resection | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Laparoscopic Hepatectomy, Hepatocellular Carcinoma | 08/18 | 08/23 | | |
NCT02950324: Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer? |
|
|
| Not yet recruiting | N/A | 50 | Europe | Prehabilitation, Standard care | Royal Surrey County Hospital NHS Foundation Trust | Cancer | 11/18 | 11/22 | | |
RHCC:BCLC-A, NCT02678806: Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion |
|
|
| Recruiting | N/A | 620 | RoW | Postoperative radiotherapy, Postoperative TACE | Guangxi Medical University | HepatoCellular Carcinoma | 11/18 | 11/22 | | |
HBOT, NCT02575014: Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy |
|
|
| Enrolling by invitation | N/A | 50 | US | Preoperative hyperbaric oxygen, O2 | Florida Hospital Tampa Bay Division | Periampullary Tumor, Common Bile Duct Neoplasms, Duodenal Neoplasms | 12/18 | 12/22 | | |
LAND, NCT03013153: Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery |
|
|
| Recruiting | N/A | 748 | RoW | Low ligation with apical lymph node dissection, LAND, High ligation, HL | Sixth Affiliated Hospital, Sun Yat-sen University | Rectal Cancer | 12/18 | 12/23 | | |
NCT02164136: Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients |
|
|
| Recruiting | N/A | 172 | RoW | L-PANP-TME, O-PANP-TME | Third Affiliated Hospital, Sun Yat-Sen University | Rectum Neoplasms | 06/19 | 06/23 | | |
CGCT-01, NCT02130752: Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery |
|
|
| Recruiting | N/A | 430 | RoW | Monopolar electrocautery, Ultrasonic scalpel | West China Hospital | Gastric Cancer, Surgery, Ultrasonic Scalpel, Monopolar Electrocautery, Operation Time, Blood Loss, Surgical, Quality of Life, External Causes of Morbidity and Mortality | 10/19 | 10/22 | | |
NCT02165800: Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients |
|
|
| Recruiting | N/A | 667 | RoW | L-PANP-TME, O-PANP-TME | Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Sixth Affiliated Hospital, Sun Yat-sen University, Nanfang Hospital of Southern Medical University, Southern Medical University, China | Rectum Neoplasms | 12/19 | 12/23 | | |
| Recruiting | N/A | 5000 | Europe | Robotic Gastrectomy, Laparoscopic Gastrectomy | International Study Group on Minimally Invasive Surgery for Gastric Cancer | Gastric Cancer | 01/20 | 12/24 | | |
NCT02942238: Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) |
|
|
| Not yet recruiting | N/A | 582 | RoW | CME, D3 | Ruijin Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, RenJi Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Fudan University | Overall Survival, Postoperative Complications, Metastasis, Stage, Colon Cancer | 01/20 | 12/22 | | |
| Recruiting | N/A | 150 | RoW | the caudal-to-cranial approach, the medial-to-lateral approach | Guangdong Provincial Hospital of Traditional Chinese Medicine | Ascending Colon Cancer, Ileocaecal Valve Carcinoma, Cancer Flexure Hepatic, Adenocarcinoma of Hepatic Flexure (Diagnosis) | 02/20 | 12/24 | | |
NCT02635087: microRNAs Tool for Stratifying Stage II Colon Cancer |
|
|
| Recruiting | N/A | 630 | RoW | miRNA tool | First Affiliated Hospital, Sun Yat-Sen University | Colonic Neoplasms, Effects of Chemotherapy | 07/20 | 07/25 | | |
NCT02313688: Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors |
|
|
| Recruiting | N/A | 320 | RoW | gastrectomy | West China Hospital | Stomach Neoplasms, Siewert Type II Adenocarcinoma of Esophagogastric Junction, Recurrence, Siewert Type III Adenocarcinoma of Esophagogastric Junction | 12/20 | 12/23 | | |
| Active, not recruiting | N/A | 12000 | NA | Capsule sponge | Tehran University of Medical Sciences, National Cancer Institute (NCI), International Agency for Research on Cancer, University of Cambridge, Golestan University of Medical Science | Esophageal Cancer | 12/20 | 12/23 | | |
| Not yet recruiting | N/A | 500 | Europe | D1 gastrectomy, D2 gastrectomy | Italian Research Group for Gastric Cancer | Gastric Cancer, Locally Advanced Malignant Neoplasm, Perioperative/Postoperative Complications | 12/20 | 12/25 | | |
NCT02886104: Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis |
|
|
| Recruiting | N/A | 548 | RoW | CRLM resection group, Hepatectomy, CRLM ablation group, Microwave ablation | Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Second Affiliated Hospital, Sun Yat-Sen University | Secondary Malignant Neoplasm of Liver | 07/21 | 07/26 | | |
| Recruiting | N/A | 30 | Europe | Organ Preservation, Transanal Endoscopic Microsurgery, Watch and Wait | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Hospital General Universitario Elche | LOCALLY ADVANCED RECTAL CANCER | 02/22 | 02/27 | | |
NCT02861209: Collaborative Network to Take Responsibility for Oral Anticancer Therapy |
|
|
| Recruiting | N/A | 228 | Europe | Implementation of a care pathway | KU Leuven | Breast Cancer, ALL, Lung Cancer, Melanoma, Colorectal Cancer, Prostate Cancer | 11/22 | 11/22 | | |
LBDL, NCT02969148: Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer |
|
|
| Recruiting | N/A | 100 | RoW | Laparoscopic bursectomy and D2 lymphadenectomy, Laparoscopic D2 lymphadenectomy | Guangdong Provincial Hospital of Traditional Chinese Medicine | Gastric Cancer Stage II, Gastric Cancer Stage III | 11/22 | 11/24 | | |
| Completed | N/A | 235 | Europe | FOLFOX, FOLFOX-4 or equivalent | Jules Bordet Institute | Colon Cancer | 12/22 | 12/22 | | |
NCT02461979: The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis |
|
|
| Recruiting | N/A | 50 | RoW | The VDR genotype | Sherief Abd-Elsalam, Tanta University | Liver Cancer | 12/22 | 12/22 | | |
NCT02514434: Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC] |
|
|
| Active, not recruiting | N/A | 416 | RoW | Ultrasonography, non-contrast MRI | Yonsei University | Compensated Liver Cirrhosis | 12/22 | 12/22 | | |
| Active, not recruiting | N/A | 33948 | RoW | Endoscopic Screening | Peking University | Esophageal Squamous Cell Carcinoma, Dysplasia | 12/22 | 12/27 | | |
| Recruiting | N/A | 3000 | Europe | | EDUARDO ALBENIZ, Fundacion Miguel Servet | Endoscopic Resection, Gastrointestinal Neoplasms | 12/22 | 12/23 | | |
NCT02920554: The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer |
|
|
| Recruiting | N/A | 88 | RoW | wedge resection, bisegmentectomy | Saint Vincent's Hospital, Korea | Gallbladder Cancer | 12/30 | 12/30 | | |
NCT01919242: Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study |
|
|
| Recruiting | N/A | 10000 | RoW | gastrectomy | Yonsei University | Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer | 09/23 | 09/23 | | |
| Active, not recruiting | N/A | 440 | US | iodinated contrast dye, iodinated radiographic dye, motexafin gadolinium, Xcytrin, Eovist-enhanced MRI | American College of Radiology Imaging Network, National Cancer Institute (NCI) | Liver Cancer | 12/23 | 12/23 | | |
NCT02969122: Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor |
|
|
| Recruiting | N/A | 59 | RoW | standard gastrectomy with D2 lymphadenectomy, hyperthermic intraperitoneal chemotherapy, HIPEC, Extensive intraperitoneal lavage, EIPL, Preoperative chemotherapy, Postoperative chemotherapy | Peking University | Stomach Neoplasm | 12/23 | 12/23 | | |
| Recruiting | N/A | 1000 | Europe | Biomarker sampling | Pia Osterlund | Metastatic Colorectal Cancer | 12/25 | 12/25 | | |
NCT02466113: A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving Adjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 430 | RoW | A 6 microRNA stratified tool, A classic stratified tool | First Affiliated Hospital, Sun Yat-Sen University, Sun Yat-sen University, Third Affiliated Hospital, Sun Yat-Sen University, Sixth Affiliated Hospital, Sun Yat-sen University | Colonic Neoplasms, Effects of Chemotherapy | 01/26 | 01/26 | | |
NCT00574327: Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry |
|
|
| Recruiting | N/A | 3000 | US | | Midwest Biomedical Research Foundation, Kansas City Veteran Affairs Medical Center | Barrett's Esophagus, Gastroesophageal Reflux Disease, Esophageal Adenocarcinoma | 10/28 | 01/29 | | |
NCT02869581: Institut Paoli-Calmettes Pancreatic Neoplasms Database |
|
|
| Recruiting | N/A | 8500 | Europe | Data collection | Institut Paoli-Calmettes | Pancreatic Neoplasms | 01/30 | 12/30 | | |
NCT02869503: Institut Paoli Calmettes Colorectal Cancer Database |
|
|
| Recruiting | N/A | 22000 | Europe | Data collection | Institut Paoli-Calmettes | Colorectal Neoplasms | 01/30 | 12/30 | | |
NCT02869477: Institut Paoli Calmettes Cardia Cancer Database |
|
|
| Recruiting | N/A | 2000 | Europe | Data collection | Institut Paoli-Calmettes | Stomach Neoplasms, Cardia | 01/30 | 12/30 | | |
| Recruiting | N/A | 10000 | Europe | Radiotherapy, Chemoradiation | University Medical Center Groningen | Esophageal Cancer | 01/30 | 01/30 | | |
| Recruiting | N/A | 1500 | Europe | Data collection | Institut Paoli-Calmettes | Pancreatic Neoplasms | 11/30 | | | |
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 3600 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |